Viewing Study NCT06556368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-03 @ 2:47 PM
Study NCT ID: NCT06556368
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2024-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
Sponsor: Kodiak Sciences Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Wet Age-related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Wet AMD View
None KSI-301 View
None KSI-501 View
None Tarcocimab View
None Tabirafusp View
None Aflibercept View
None Antibody biopolymer conjugate View
None AMD View
None Anti-VEGF View
None Vascular endothelial growth factor View
None Kodiak Sciences View